Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 6/20 | 0.60 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.60 |
| ▸ | BCHE | P06276 | 5/20 | 0.54 |
| ▸ | ACHE | P22303 | 5/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2381090 | 1.00 | OPRL1 (0.60) | OPRL1OPRM1BCHEACHEMEN1 | |
| Hydrochloric Acid SCHEMBL2381559 | 0.99 | OPRL1 (0.61) | OPRL1OPRM1BCHEACHEMEN1 | |
| Hydrochloric Acid SCHEMBL301694 | 0.99 | OPRL1 (0.61) | OPRL1OPRM1BCHEACHEMEN1 | |
| SCHEMBL303134 | 0.99 | OPRL1 (0.61) | OPRL1OPRM1BCHEACHEMEN1 | |
| Hydrochloric Acid SCHEMBL2380272 | 0.98 | OPRL1 (0.62) | OPRL1OPRM1BCHEACHEMEN1 | |
| SCHEMBL2379196 | 0.96 | OPRL1 (0.62) | OPRL1OPRM1BCHEACHEMEN1 | |
| Hydrochloric Acid SCHEMBL302176 | 0.95 | OPRL1 (0.63) | OPRL1OPRM1BCHEACHEMEN1 | |
| SCHEMBL2379029 | 0.93 | OPRL1 (0.67) | OPRL1OPRM1BCHEACHEMEN1 | |
| Hydrochloric Acid SCHEMBL302553 | 0.92 | OPRL1 (0.68) | OPRL1OPRM1BCHEACHEMEN1 | |
| SCHEMBL2378435 | 0.87 | OPRL1 (0.66) | OPRL1OPRM1BCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8017630-B2 | Cyclohexylacetic acid compounds | GRUENENTHAL GMBH (DE) | 2011-09-13 | — | — | US | claimed |
| EP-1751093-B1 | SUBSTITUTED CYCLOHEXYLACETIC ACID DERIVATIVES | GRUENENTHAL GMBH (DE) | 2010-10-06 | — | — | EP | claimed |
| US-20070129347-A1 | Cyclohexylacetic acid compounds | GRUENENTHAL GMBH (DE) | 2007-06-07 | — | — | US | claimed |
| US-8017630-B2 | Cyclohexylacetic acid compounds | GRUENENTHAL GMBH (DE) | 2011-09-13 | — | — | US | disclosed |
| EP-1751093-B1 | SUBSTITUTED CYCLOHEXYLACETIC ACID DERIVATIVES | GRUENENTHAL GMBH (DE) | 2010-10-06 | — | — | EP | disclosed |
| US-20070129347-A1 | Cyclohexylacetic acid compounds | GRUENENTHAL GMBH (DE) | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129347-A1 | Cyclohexylacetic acid compounds | ACACA, HCAR2, PCCA | OPRL1 2478/4885OPRM1 3702/4885BCHE 806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.